Urokinase (u-PA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy. - Kuhn,W.; Pache,L.; Schmalfeldt,B.; Dettmar,P.; Schmitt,M.; Jänicke,F.; Graeff,H. (Gynecol Oncol, 1994)